| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/03/2008 | CN101314769A Staphylokinase and expression vector thereof |
| 12/03/2008 | CN101313991A Capsule for thrombocytopenic purpura |
| 12/03/2008 | CN101313983A Compound garlic soft capsule |
| 12/03/2008 | CN101313981A Compound caulis spatho lobi effervescent tablet for anemia |
| 12/03/2008 | CN101313978A Bacillus coli vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof |
| 12/03/2008 | CN101313964A Medicine for treating hydrocephalus |
| 12/03/2008 | CN101313953A Medicament composition for treating idiopathic thromboeytopenic purpura and preparation method thereof |
| 12/03/2008 | CN101313923A Polyphenol extracted from pistacia chinensis cake and extracting method thereof |
| 12/03/2008 | CN101313873A Biology polypeptide medicament blood vessel bracket and preparation method thereof |
| 12/03/2008 | CN101313771A Solid beverage tablet of kudzu root containing gas and preparation technique |
| 12/03/2008 | CN101313730A Pig feed containing Chinese medicinal herb and preparation method thereof |
| 12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439351C Benzofuran derivative |
| 12/03/2008 | CN100439329C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 12/03/2008 | CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |
| 12/03/2008 | CN100438858C Preparation method of Chinese clinopodium herb effervescence tablet |
| 12/02/2008 | US7459569 Reacting maltol or ethyl maltol with a ferric salt of citric acid, isocitric acid, succinic acid, fumaric acid, maleic acid, malonic acid, aconitic acid, glutaric acid, tartaric acid, gluconic acid, or lactic acid in an aqueous solution containing alkali metal hydroxide or sodium or potassium carbonate |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459534 Inactivation resistant factor VIII |
| 12/02/2008 | US7459525 Glycosylated protein for use in the treatment of blood disorders |
| 12/02/2008 | US7459478 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 12/02/2008 | US7459438 sustained relese of saratin polypeptide to prevent platelet adhesion after vascular injury; thrombosis and restenosis inhibitor |
| 12/02/2008 | US7459436 Administering erythropoietin or derivative to treat diabetes |
| 12/02/2008 | US7459435 Administering erythropoietin or derivative to human suffering from diabetes |
| 12/02/2008 | US7459431 Recombinant gelatin-like proteins for use as plasma expanders |
| 12/02/2008 | US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells |
| 12/02/2008 | US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery |
| 12/02/2008 | US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot |
| 12/02/2008 | CA2282843C Purification of von willebrand factor by cation exchange chromatography |
| 12/02/2008 | CA2282841C A method of purifying factor viii/vwf-complex by means of cation exchange chromatography |
| 12/02/2008 | CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide |
| 11/27/2008 | WO2008143812A2 Biologic devices for hemostasis |
| 11/27/2008 | WO2008073670A3 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor |
| 11/27/2008 | US20080293790 Substituted aryl oximes |
| 11/27/2008 | US20080293785 Substituted benzothiazole kinase inhibitors |
| 11/27/2008 | US20080293704 FACTOR Xa INHIBITORS |
| 11/27/2008 | US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 11/27/2008 | US20080293628 Methods and Compositions for the Inhibition of Thrombus Formation |
| 11/27/2008 | US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 11/27/2008 | US20080292605 Materials for stimulation of hematopoiesis by ex vivo activated cells |
| 11/27/2008 | US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/27/2008 | CA2685942A1 Spiroindalones |
| 11/27/2008 | CA2685222A1 Methods of reducing eosinophil levels |
| 11/26/2008 | EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 11/26/2008 | EP1994941A2 Medicine containing at least one oxidised protein |
| 11/26/2008 | EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 11/26/2008 | EP1993514A2 Granular material comprising water-insoluble inorganic phosphate binders |
| 11/26/2008 | EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 11/26/2008 | EP1506162B1 Synthesis of benzonitriles and benzimidates |
| 11/26/2008 | EP1419173B1 Peptides that bind to atherosclerotic lesions |
| 11/26/2008 | EP1414455B1 Isoquinoline inhibitors of p38 |
| 11/26/2008 | EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 11/26/2008 | CN101312747A Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 11/26/2008 | CN101312722A Modulators of atp-binding cassette transporters |
| 11/26/2008 | CN101310728A Free protein blood of pig injection and use thereof |
| 11/26/2008 | CN100436482C Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods |
| 11/26/2008 | CN100436439C Dimeric isoflavones |
| 11/26/2008 | CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 11/26/2008 | CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 11/26/2008 | CN100435798C Preparation of ligustrazine and ligustrazine salt drop pills utilizing nano technology |
| 11/26/2008 | CN100435792C Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease |
| 11/26/2008 | CN100435755C Bracket for eluting medication |
| 11/25/2008 | US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls. |
| 11/25/2008 | US7456195 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 11/25/2008 | US7456183 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |
| 11/25/2008 | US7456158 4-dedimethylaminotetracycline derivatives |
| 11/25/2008 | US7456148 Using apolipoprotein as therapeutic agent which prevents and treats thrombosis in cardiovascular and ischemia-reperfusion injuries |
| 11/25/2008 | US7455987 Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture medium |
| 11/25/2008 | US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody |
| 11/25/2008 | US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule |
| 11/25/2008 | CA2383212C Controlled release oral dosage suitable for oral administration |
| 11/25/2008 | CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity |
| 11/25/2008 | CA2333252C Use of bromelain proteases for inhibiting blood coagulation |
| 11/25/2008 | CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 11/25/2008 | CA2140971C A stable freeze-dried hirudin composition |
| 11/20/2008 | WO2008140220A1 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 11/20/2008 | WO2008139845A1 Novel amide derivative |
| 11/20/2008 | WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 11/20/2008 | WO2008138754A2 New solid forms of fxa inhibitors |
| 11/20/2008 | WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators |
| 11/20/2008 | US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade |
| 11/20/2008 | US20080287501 Therapeutic uses of an insulin secretion enhancer |
| 11/20/2008 | US20080287478 Nociceptin Analogues and Uses Thereof |
| 11/20/2008 | US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof |
| 11/20/2008 | US20080287411 Optically active dihydropyridine derivative |
| 11/20/2008 | US20080287390 Pyrazolidinol compounds |
| 11/20/2008 | US20080287370 Boronic Acid Salts Useful in Parenteral Formulations |
| 11/20/2008 | US20080287365 administering lactoferrin and the toll-like receptor ligand polyinosinic-polycytidylic acid to an animal |
| 11/20/2008 | US20080287342 Compositions Comprising Modified Collagen and Uses Therefor |
| 11/20/2008 | US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 11/20/2008 | US20080286376 Dry hemostatic compositions and methods for their preparation |
| 11/20/2008 | US20080286347 Bioabsorbable synthetic nonwoven fabric holding thrombin |
| 11/20/2008 | US20080286260 Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara) |
| 11/20/2008 | US20080286259 Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
| 11/20/2008 | US20080286246 Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| 11/20/2008 | CA2687266A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells |
| 11/20/2008 | CA2685761A1 New solid forms of fxa inhibitors |
| 11/19/2008 | EP1991538A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors |
| 11/19/2008 | EP1991271A2 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |